Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Revenue

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹2,623 Cr₹2,177 Cr₹1,852 Cr₹1,491 Cr₹1,376 Cr

What is the latest Revenue of MARKSANS PHARMA ?

The latest Revenue ratio of MARKSANS PHARMA is ₹2,623 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹2,623 Cr
Mar2024₹2,177 Cr
Mar2023₹1,852 Cr
Mar2022₹1,491 Cr
Mar2021₹1,376 Cr

How is Revenue of MARKSANS PHARMA Trending?

Years Revenue % Change
Mar2025 ₹2,623 Cr
20.46
Mar2024 ₹2,177 Cr
17.56
Mar2023 ₹1,852 Cr
24.23
Mar2022 ₹1,491 Cr
8.33
Mar2021 ₹1,376 Cr -

Compare Revenue of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,448.3 Cr 4% -7% -29.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹105,961.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -4.6% -7% 1.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

4%

-7%

-29.8%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses